Karen L. Parkhill - 01 Aug 2022 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
4
Filing time
03 Aug 2022, 17:24:28 UTC
Previous filing
02 Aug 2022
Next filing
04 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Award $0 +10,744 +53% $0.000000 30,962 01 Aug 2022 Direct F1
holding MDT Ordinary Shares 49,859 01 Aug 2022 Jeffrey S. Parkhill 2021 Irrevocable Trust F2
holding MDT Ordinary Shares 843 01 Aug 2022 By Child #1
holding MDT Ordinary Shares 843 01 Aug 2022 By Child #2
holding MDT Ordinary Shares 843 01 Aug 2022 By Child #3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Units Award $0 +26,859 $0.000000 26,859 01 Aug 2022 Performance Share Units 26,859 Direct F3, F4, F5
transaction MDT Stock Option (Right to Buy) Award $0 +84,905 $0.000000 84,905 01 Aug 2022 Ordinary Shares 84,905 $93.08 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F2 These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.
F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F4 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 26,859 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F5 Vests on August 1, 2025.
F6 These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.